XML 26 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders' Equity
12 Months Ended
Jan. 02, 2024
Equity [Abstract]  
Shareholders' Equity

10. Shareholders’ Equity

At-the-Market Offering

On January 21, 2021, we sold 703,399 shares of our common stock at $42.65 per share for cash proceeds of $30.0 million (before commission and other fees) through an at-the market (“ATM”) offering program. As a result of the anti-dilution provisions contained in ACT III’s warrant, the number of shares issuable upon exercise of such warrant was adjusted to 876,949 and the exercise price was adjusted to $26.94. The warrant expires on May 4, 2025, five years following the issuance.

Preferred Stock

We are authorized to issue 5.0 million shares of one or more series of preferred stock and we are authorized to determine the rights, preferences, privileges and restrictions to be granted to, or imposed upon, any such series, including the voting rights, redemption provisions (including sinking fund provisions), dividend rights, dividend rates, liquidation rates, liquidation preferences, conversion rights and the description and number of shares constituting any wholly unissued series of preferred stock. No shares of preferred stock were issued or outstanding at January 2, 2024 or January 3, 2023. We currently have no plans to issue shares of preferred stock.

Common Stock

Shareholders are entitled to one vote for each share of common stock held of record. Pursuant to the requirements of California law, shareholders are entitled to accumulate votes in connection with the election of directors. Shareholders of our outstanding common stock are entitled to receive dividends if and when declared by the Board of Directors.

Cash Dividends

Quarterly cash dividends are suspended until our Board of Directors determines that the resumption of dividend payments is in the best interest of the Company and its shareholders. As such, the only cash dividends paid during fiscal 2023 and 2022 were related to dividends (declared prior to fiscal 2020) on restricted stock grants, which vested under our stock-based compensation plans.

Stock Repurchases

During fiscal 2023, we repurchased and retired approximately 428,000 shares of our common stock at an average price of $25.71 per share for a total of approximately $11.0 million, which is recorded as a reduction in common stock, with any excess charged to retained earnings. As of January 2, 2024, we have approximately $11.1 million remaining under the current $500 million share repurchase plan approved by our Board of Directors. Repurchases may be made at any time. In February 2024, our Board of Directors approved an increase in our share repurchase program by $50 million. As a result, we currently have approximately $61.1 million available under our authorized $550 million share repurchase program.